Lindbrook Capital, LLC Outset Medical, Inc. Transaction History

Lindbrook Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	BUY	$10.52 - $20.68 $547 - $1,075	52 Added 40.63%	180 $1,000
Q2 2023 Jul 28, 2023	SELL	$17.18 - $23.76 $1,030 - $1,425	-60 Reduced 31.91%	128 $2,000
Q1 2023 Apr 26, 2023	SELL	$18.25 - $30.26 $1,971 - $3,268	-108 Reduced 36.49%	188 $3,000
Q4 2022 Jan 24, 2023	SELL	$12.36 - $26.41 $1,656 - $3,538	-134 Reduced 31.16%	296 $0
Q3 2022 Nov 10, 2022	BUY	$14.67 - $21.7 $3,095 - $4,578	211 Added 96.35%	430 $7,000

Q2 2022 Aug 01, 2022	BUY	$13.46 - $48.16 $673 - $2,408	50 Added 29.59%	219 $3,000
Q1 2022 Apr 21, 2022	BUY	$34.22 - $47.24 $5,783 - $7,983	169 New	169 $8,000

122

41M

63.4K

32.1K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $181M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.